Status:
UNKNOWN
Subconjunctival Bevacizumab Effect on Bleb Vascularity
Lead Sponsor:
Rabin Medical Center
Conditions:
Bleb Vascularity
Bleb Fibrosis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Trabeculectomy is an ocular surgery intended to reduce intra-ocular pressure the surgery creates a sub-conjunctival filtering bleb which filters aqueous humor fluid out. A rather common adverse event...
Detailed Description
trabeculectomy is an ocular surgery intended to reduce intra-ocular pressure the surgery creates a sub-conjunctival filtering bleb which filters aqueous humor fluid out. a rather common adverse event...
Eligibility Criteria
Inclusion
- post uneventful trabeculectomy with mitomycin c application during surgery
- adult
Exclusion
- usage of 5-fluorouracil in trabeculectomy
- post-operative complications
- ischemic heart disease
- s/p cerebrovascular accident
- allergy to bevacizumab
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00854529
Start Date
April 1 2009
End Date
October 1 2011
Last Update
March 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 49100